Early test of new obesity drug combo shows promise
NCT ID NCT06297616
Summary
This early-stage study tested the safety and effects of a new drug called LY3841136, both by itself and combined with the existing weight-loss medication tirzepatide. It involved 128 Japanese adults who were living with obesity or overweight. The main goals were to check for side effects, see how the body processes the drug, and measure changes in body weight over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hakata Clinic
Fukuoka, 812-0025, Japan
-
P-One Clinic
Hachiōji, Tokyo, 192-0071, Japan
-
Sumida Hospital
Sumida-ku, Tokyo, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.